SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
58 hedge funds and large institutions have $87.2M invested in Strongbridge Biopharma plc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+7
Holders Change %
+13.73%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
19
Reduced
17
Closed
12
Calls
$8K
Puts
$2K
Net Calls
+$6K
Net Calls Change
+$32K
Top Buyers
| 1 |
BlackRock
New York
|
+$5.32M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$5.05M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.52M |
| 4 |
2L
22NW LP
Seattle,
Washington
|
+$1.25M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$814K |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.74M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$4.55M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$3.9M |
| 4 |
AC
Armistice Capital
New York
|
-$2.85M |
| 5 |
BC
Broadfin Capital
New York
|
-$774K |
